The Importance of Lassa Fever and Its Disease Management in West Africa
- PMID: 38400041
- PMCID: PMC10892767
- DOI: 10.3390/v16020266
The Importance of Lassa Fever and Its Disease Management in West Africa
Abstract
Lassa virus (LASV) is a zoonotic pathogen endemic throughout western Africa and is responsible for a human disease known as Lassa fever (LF). Historically, LASV has been emphasized as one of the greatest public health threats in West Africa, with up to 300,000 cases and 5000 associated deaths per year. This, and the fact that the disease has been reported in travelers, has driven a rapid production of various vaccine candidates. Several of these vaccines are currently in clinical development, despite limitations in understanding the immune response to infection. Alarmingly, the host immune response has been implicated in the induction of sensorineural hearing loss in LF survivors, legitimately raising safety questions about any future vaccines as well as efficacy in preventing potential hearing loss. The objective of this article is to revisit the importance and prevalence of LF in West Africa, with focus on Nigeria, and discuss current therapeutic approaches and ongoing vaccine development. In addition, we aim to emphasize the need for more scientific studies relating to LF-associated hearing loss, and to promote critical discussion about potential risks and benefits of vaccinating the population in endemic regions of West Africa.
Keywords: Lassa virus; arenavirus; sensorineural hearing loss.
Conflict of interest statement
All authors declare no financial or non-financial competing interests.
Similar articles
-
Lassa fever-induced sensorineural hearing loss: A neglected public health and social burden.PLoS Negl Trop Dis. 2018 Feb 22;12(2):e0006187. doi: 10.1371/journal.pntd.0006187. eCollection 2018 Feb. PLoS Negl Trop Dis. 2018. PMID: 29470486 Free PMC article. Review.
-
Current research for a vaccine against Lassa hemorrhagic fever virus.Drug Des Devel Ther. 2018 Aug 14;12:2519-2527. doi: 10.2147/DDDT.S147276. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30147299 Free PMC article. Review.
-
The search for animal models for Lassa fever vaccine development.Expert Rev Vaccines. 2013 Jan;12(1):71-86. doi: 10.1586/erv.12.139. Expert Rev Vaccines. 2013. PMID: 23256740 Free PMC article. Review.
-
Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines.Vaccine. 2025 Jan 1;43(Pt 1):126525. doi: 10.1016/j.vaccine.2024.126525. Epub 2024 Nov 22. Vaccine. 2025. PMID: 39579650 Review.
-
A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene.mBio. 2020 Feb 25;11(1):e00039-20. doi: 10.1128/mBio.00039-20. mBio. 2020. PMID: 32098811 Free PMC article.
Cited by
-
Animal Models of Pathogenic New World Arenaviruses.Microorganisms. 2025 Jun 11;13(6):1358. doi: 10.3390/microorganisms13061358. Microorganisms. 2025. PMID: 40572246 Free PMC article. Review.
-
The first imported case of Lassa fever in China: a case description.Quant Imaging Med Surg. 2025 Jan 2;15(1):1066-1072. doi: 10.21037/qims-24-1784. Epub 2024 Nov 22. Quant Imaging Med Surg. 2025. PMID: 39839037 Free PMC article. No abstract available.
References
-
- Centers for Disease Control and Prevention . Lassa Fever: Outbreak Distribution Map. Centers for Disease Control and Prevention; Atlanta, GA, USA: 2014.
-
- Safronetz D., Safronetz D., Rosenke K., Meade-White K., Sloan A., Maiga O., Bane S., Martellaro C., Scott D.P., Sogoba N., et al. Temporal analysis of Lassa virus infection and transmission in experimentally infected Mastomys natalensis. PNAS Nexus. 2022;1:pgac114. doi: 10.1093/pnasnexus/pgac114. - DOI - PMC - PubMed
-
- Centers for Disease Control and Prevention Lassa Fever. [(accessed on 1 January 2023)];2015 Available online: https://www.cdc.gov/vhf/lassa/index.html.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources